◂ Last issue Next issue ▸ Archive Cover PDF   

Volume 2 (5); 2012

Editorial

Molecular Imaging and Radiotherapy: Theranostics for Personalized Patient Management
Irina Velikyan
Theranostics 2012; 2(5): 424-426. doi:10.7150/thno.4428
Full text PDF PubMed PMC

Research Paper

Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 Pentetreotide
Ebrahim S. Delpassand, Amin Samarghandi, Jennifer Sims Mourtada, Sara Zamanian, Gregory D. Espenan, Roozbeh Sharif, Shawn MacKenzie, Kambiz Kosari, Omar Barakat, Shagufta Naqvi, John E. Seng, Lowell Anthony
Theranostics 2012; 2(5): 472-480. doi:10.7150/thno.3739
Full text PDF PubMed PMC

Reviews

How Does the Patient Benefit from Clinical PET?
Jens Sörensen
Theranostics 2012; 2(5): 427-436. doi:10.7150/thno.3794
Full text PDF PubMed PMC

THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience
Richard P. Baum, Harshad R. Kulkarni
Theranostics 2012; 2(5): 437-447. doi:10.7150/thno.3645
Full text PDF PubMed PMC

Molecular Imaging Radiotherapy: Theranostics for Personalized Patient Management of Neuroendocrine Tumors (NETs)
Kjell Öberg
Theranostics 2012; 2(5): 448-458. doi:10.7150/thno.3931
Full text PDF PubMed PMC

Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer
M. Fani, H. R. Maecke, S. M. Okarvi
Theranostics 2012; 2(5): 481-501. doi:10.7150/thno.4024
Full text PDF PubMed PMC

Imaging Key Biomarkers of Tumor Angiogenesis
Marina V. Backer, Joseph M. Backer
Theranostics 2012; 2(5): 502-515. doi:10.7150/thno.3623
Full text PDF PubMed PMC

Imaging of Adrenal Masses with Emphasis on Adrenocortical Tumors
Anders Sundin
Theranostics 2012; 2(5): 516-522. doi:10.7150/thno.3613
Full text PDF PubMed PMC

Pretargeted Molecular Imaging and Radioimmunotherapy
David M. Goldenberg, Chien-Hsing Chang, Edmund A. Rossi, William J. McBride, Robert M. Sharkey
Theranostics 2012; 2(5): 523-540. doi:10.7150/thno.3582
Full text PDF PubMed PMC

Case Report

Lessons on Tumour Response: Imaging during Therapy with ¹⁷⁷Lu-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine Carcinoma
Ulrike Garske, Mattias Sandström, Silvia Johansson, Dan Granberg, Hans Lundqvist, Mark Lubberink, Anders Sundin, Barbro Eriksson
Theranostics 2012; 2(5): 459-471. doi:10.7150/thno.3594
Full text PDF PubMed PMC

©2024 Ivyspring International Publisher. Terms of use